Track the 天康生物 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Food & Beverage sector, 天康生物 has published 1 reports. Market capitalisation: €9.8bn. The latest transaction was filed on 7 September 2022 (Sale). Among the most active insiders: 王潇. Every trade is openly available.
Analysts rate 天康生物 Strong Buy (bullish), based on 4 analysts. Average price target: CN¥8.15.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
天康生物是一家专注于农产品领域的公司,致力于生物产品的研发。该公司在XSHE市场上市。